Políticas Médicas

Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.

Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.

Tabla de Políticas Médicas

ID Título Revisión Descripción Acceso
11.003.014 Noninvasive Fetal Rhd Genotyping Using Cell-Free Fetal Dna Sep 2026 Rhesus d (rhd)-negative women who are exposed to rhd-positive red blood cells can develop anti-rhd... Ver
11.003.015 Gene Expression Profile Testing And Circulating Tumor Dna Testing For Predicting Recurrence In Colon Cancer Sep 2026 Gene expression profile (gep) and tumor-naïve circulating tumor dna (ctdna) tests have been developed... Ver
11.003.016 Genetic Testing For Pten Hamartoma Tumor Syndrome Mar 2026 The pten hamartoma tumor syndrome (phts) includes several syndromes with heterogeneous clinical symptoms,... Ver
11.003.017 Genetic Testing For Hereditary Hearing Loss May 2026 Hearing loss is a common birth defect. approximately 1 in 500 newborns in developed countries is affected by... Ver
11.003.018 Chromosomal Microarray Testing For The Evaluation Of Pregnancy Loss Sep 2026 Chromosomal microarray (cma) testing of fetal tissue or placental tissue derived from the fetal genotype has... Ver
11.003.020 Genetic Testing For Lactase Insufficiency Jul 2024 Genetic testing of adults with suspected lactase insufficiency is proposed as an alternative to current... Ver
11.003.021 Gene Expression Testing In The Evaluation Of Patients With Stable Ischemic Heart Disease Apr 2021 Expression levels of various genes in circulating white blood cells or whole blood samples have been reported... Ver
11.003.022 Genetic Testing For Li-Fraumeni Syndrome Aug 2026 Li-fraumeni syndrome (lfs) is a cancer predisposition syndrome associated with the development of several... Ver
11.003.025 Genetic Testing For Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, And Congenital Anomalies Nov 2025 Chromosomal microarray (cma) testing has been proposed for the detection of genetic imbalances in infants or... Ver
11.003.026 Comprehensive Genomic Profiling for Selecting Targeted Cancer Therapies Sep 2026 Comprehensive genetic profiling offers the potential to evaluate a large number of genetic markers at a... Ver
11.003.027 Gene Variants Associated With Breast Cancer In Individuals At High Breast Cancer Risk. Sep 2026 It is estimated that 3% to 5% of women presenting for assessment for hereditary breast/ovarian cancer risk... Ver
11.003.028 Genetic Testing For Lynch Syndrome And Other Inherited Colon Cancer Syndromes Oct 2026 Genetic testing is available for both those with and those at risk for various types of hereditary cancer.... Ver
11.003.029 Epithelial Cell Cytology In Breast Cancer Risk Assesment And High-Risk Patient Management (Ductal Labage And Suction Collection Systems) May 2019 In summary, the available literature regarding ductal lavage and suction collection systems for breast cancer... Ver
11.003.030 Genetic Testing For Brca1 Or Brca2 For Hereditary Breast/Ovarian Cancer Syndrome And Other High-Risk Cancers Sep 2026 <h2 style="break-inside: avoid; break-after: avoid; font-family: arial; font-size: 20px !important;... Ver
11.003.031 Genetic Testing For Hereditary Hemochromatosis Jun 2026 Hereditary hemochromatosis (hh), a common genetic disorder of iron metabolism, can lead to inappropriate iron... Ver
11.003.032 Analysis Of Human Dna In Stool Samples As A Technique For Colorectal Cancer Screening Jan 2026 Of safety and effectiveness data (ssed): cologuard. august 2014. accessed oct 23,... Ver
11.003.034 Genetic And Protein Biomarkers For The Diagnosis And Cancer Risk Assessment Of Prostate Cancer Aug 2026 Various genetic and protein biomarkers are associated with prostate cancer. these tests have the potential to... Ver
11.003.036 Genetic Testing For Familial Cutaneous Malignant Melanoma Apr 2026 Cutaneous melanoma is the third most common type of skin cancer, but the most lethal. some cases of cutaneous... Ver
11.003.037 Analyte Testing in Risk Assessment and Management of Cardiovascular Disease Sep 2026 Numerous lipid and non-lipid biomarkers have been proposed as potential risk markers for cardiovascular... Ver
11.003.039 Pharmacogenomic And Metabolite Markers For Patients Treated With Thiopurines Dec 2025 The thiopurine class of drugs, which include azathioprine (a pro-drug for mercaptopurine), mercaptopurine,... Ver